Cargando…

Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells

Objective: Currently, sorafenib is the main systemic chemotherapy drug for advanced stage of hepatocellular carcinoma (HCC). However, emerging data from some clinical HCC patients indicates that sorafenib alone has only moderate antitumor efficacy, and could not inhibit metastasis and progression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Hongqiao, Yang, Yang, Peng, Fenghui, Liu, Yahui, Fu, Xueqi, Ji, Bai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909811/ https://www.ncbi.nlm.nih.gov/pubmed/31839741 http://dx.doi.org/10.7150/ijms.37427

Ejemplares similares

Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells
por: Liu, Jianhua, et al.
Publicado: (2017)

miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2021)

Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis
por: Jin, Mengdi, et al.
Publicado: (2021)

MiR‐221‐3p and miR‐92a‐3p enhances smoking‐induced inflammation in COPD
por: Shen, Yahui, et al.
Publicado: (2021)

Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance
por: Yun, Jong Hyuk, et al.
Publicado: (2022)

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
por: Xue, Hui-Ying, et al.
Publicado: (2016)

Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015)

Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018)

miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
por: Liu, Kai, et al.
Publicado: (2022)

Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
por: Salvi, Alessandro, et al.
Publicado: (2013)

High HBV Load Weakens Predictive Effect of Serum miR-122 on Response to Sorafenib in Hepatocellular Carcinoma Patients
por: Zhang, Xiaomin, et al.
Publicado: (2021)

MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2
por: Fu, Yi, et al.
Publicado: (2019)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021)

CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3
por: Jin, Xiaoxin, et al.
Publicado: (2018)

miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li, Feng, et al.
Publicado: (2018)

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
por: Kissel, Maria, et al.
Publicado: (2017)

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
por: Zhang, Chun-Zhi, et al.
Publicado: (2010)

Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound
por: Zhang, Libo, et al.
Publicado: (2023)

Expression and prognostic significance of miR-375 and miR-221 in liver cancer
por: Xie, Dafei, et al.
Publicado: (2017)

MiR-221 negatively regulates innate anti-viral response
por: Du, Hongqiang, et al.
Publicado: (2018)

Plasma Levels of microRNA-221 (miR-221) are Increased in Patients with Acute Pulmonary Embolism
por: Liu, Tingwei, et al.
Publicado: (2018)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction]
Publicado: (2023)

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Pinjaroen, Nutcha, et al.
Publicado: (2023)

Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
por: Li, Zihuang, et al.
Publicado: (2020)

Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model
por: Choi, Boram, et al.
Publicado: (2017)

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
por: Wu, Man, et al.
Publicado: (2018)

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022)

MiR-221 and miR-130a Regulate Lung Airway and Vascular Development
por: Mujahid, Sana, et al.
Publicado: (2013)

Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis
por: Li, Fanfan
Publicado: (2020)

The regulation roles of miR-125b, miR-221 and miR-27b in porcine Salmonella infection signalling pathway
por: Yao, Min, et al.
Publicado: (2016)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma
por: Sun, Jiao, et al.
Publicado: (2023)

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
por: Ji, Lin, et al.
Publicado: (2020)

HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma
por: Shi, Yang, et al.
Publicado: (2020)

Biomarker Value of miR-221 and miR-222 as Potential Substrates in the Differential Diagnosis of Papillary Thyroid Cancer Based on Data Synthesis and Bioinformatics Approach
por: Cai, Shang, et al.
Publicado: (2022)

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Zhang, Jianxiu, et al.
Publicado: (2022)

Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
por: Deng, Lifen, et al.
Publicado: (2013)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_767cs625bbkcjjh43l22brul12